Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Products & comparisons
Product source

NMN 400 mg by Dr. Emil Nutrition: DSLD Label Record 321809

A NIH DSLD record for the capsule product NMN 400 mg (brand Dr. Emil Nutrition) lists one declared ingredient, SIRTality (nicotinamide mononucleotide), at 400 mg per labelled serving. The record is a label declaration only and shows no efficacy, safety or approval. [1]

Automatic summary · not editorially reviewed

Label · NIH DSLD
NMN 400 mgOriginal label · NIH DSLD
NMN 400 mg

FROM THE ORIGINAL LABEL

A closer look at the product

Pack contents
30 Capsule(s)
Label serving
1 Capsule(s)
Servings per container
30
Barcode / SKU
8 50002 95667 2
Open original label (PDF)
Ingredients & declared amounts1

Amounts from the label, per specified serving. These are manufacturer declarations, not a personal dosage recommendation.

IngredientAmountPer label serving
SIRTality400 mg1 Capsule(s)

Other ingredients: Microcrystalline Cellulose, Dicalcium Phosphate Anhydrous, Magnesium Stearate, Silicon Dioxide, Hypromellose

Source: National Institutes of Health, Office of Dietary Supplements · Dietary Supplement Label Database. Label snapshot; packaging and formulation may have changed.

The key findings

  1. DSLD record 321809 lists the label name NMN 400 mg and brand Dr. Emil Nutrition. [1]

  2. The label declares SIRTality (nicotinamide mononucleotide) at 400 mg per labelled serving in capsule form. [1]

  3. DSLD inclusion does not establish efficacy, safety, FDA approval, laboratory verification or retail availability. [1]

The source at a glance

Brand
Dr. Emil Nutrition
Form
Capsule
Pack contents
30 Capsule(s)
Label serving
1 Capsule(s)
Ingredients listed
SIRTality
Record type / format
Product label/database record (NIH DSLD entry 321809); not a study.
Scope / context
The described product: NMN 400 mg capsules by Dr. Emil Nutrition, not a patient population.
Summary based on
Product label / database record

Product and database record identified

This page is a record in the NIH Office of Dietary Supplements Dietary Supplement Label Database (DSLD), entry 321809. The label name is NMN 400 mg and the declared brand is Dr. Emil Nutrition. The label entered DSLD on 2025-01-23; the source notes this is not a product launch date. DSLD is a database of label declarations, so the record describes what the label states, not what the product does.

Supporting source [1]

Capsule form and declared SIRTality amount

The physical form on the label is a capsule. The DSLD product category is Non-Nutrient/Non-Botanical. One ingredient is declared: SIRTality, with the labelled form nicotinamide mononucleotide, at 400 mg per labelled serving. The source states these amounts are label facts, not personal dosing advice. No other ingredients or amounts are given in this record.

Supporting source [1]

What the DSLD listing does not establish

The source states that inclusion in DSLD does not establish efficacy, safety, FDA approval, laboratory verification or current retail availability. No independent product testing, price or batch certificate is supplied by this record. The record is a snapshot of label declarations only.

Supporting source [1]

How to interpret this

Product label record; not evidence of efficacy or approval. Abstract-level scope does not apply; this is a database entry, and no independent testing, price or batch certificate is supplied.

Based on a product label or database record. This does not establish effectiveness, independent batch testing, approval or current availability.

Source & supporting passages

[1]
NMN 400 mg

Dr. Emil Nutrition · dsld.od.nih.gov

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    Product label name: NMN 400 mg
  2. Finding 2 ↑

    Nicotinamide Mononucleotide): 400 mg per labelled serving
  3. Finding 3 ↑

    does not establish efficacy, safety, FDA approval

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…